Approved comparison material connected to this topic.
4 total recordsSource comparisons are presented without a generated winner.
CJC-1295 No DAC GHRH receptor agonist ~30 minutes Injection site reaction (10–15%), flushing (5–8%) None documented 90-day trials, no serious adverse events Ipamorelin Selective ghrelin receptor agonist ~2 hou…
8–12 weeks 3–5x weekly, 100–200mcg each peptide Improved recovery markers, lean mass retention, sleep quality enhancement Mild water retention (12–18%), transient injection site reaction (8%), fasting glucose …
Here's the honest answer: most 'long-term peptide safety studies' cited online aren't clinical trials. They're observational case series or self-reported logs with no control group, no blinding, and no standar…
Mechanism Stimulates endogenous pituitary GH release in natural pulses Replaces natural GH with constant exogenous supply Peptides preserve physiological feedback loops; rhGH overrides them Side Effect Inciden…